Canga L, Sterin-Borda L, Borda E S, Peredo H, Gimeno A L
Eur J Pharmacol. 1985 Mar 26;110(1):47-54. doi: 10.1016/0014-2999(85)90027-5.
Contractile responses to exogenous sodium arachidonate (NaA) were studied in auricles from normal and acutely diabetic (streptozotocin-treated) rats. NaA induced a concentration-dependent positive inotropic effect in atria from normal and diabetic rats but the magnitude of the contractile influence of the fatty acid was different in both types of auricles, i.e. diabetic atria had a greater responsiveness to NaA than normal preparations. Blockers of arachidonic acid (AA) metabolism via cyclo-oxygenase (indomethacin and acetylsalicylic acid), abolished the stimulatory influence of NaA in normal and in diabetic auricles. Moreover, incubation with tranylcipromine, a prostacyclin synthetase inhibitor, reduced the inotropic effect of NaA in normal atria, but failed to modify it in the diabetic atria. On the other hand, inhibitors of thromboxane (TX) synthetase (imidazole and L-8027) diminished the effect of NaA in diabetic preparations without altering the contractile responses in the controls. In the presence of lipoxygenase blocking agents (nordihydroguaiaretic acid and dithizone), the influence of NaA was reduced at normal values only in the atria from diabetic rats. Both atrial preparations (normal and diabetic) converted ([1-14C]arachidonic acid (AA) into PGI2 (assessed as 6-oxo-PGF1 alpha) and TXB2. Moreover, normal atria generated more PGI2 than TXB2 whereas TXB2 production was greater than that of PGI2 in diabetic atria. The foregoing results suggest that in non-diabetic atria the effect of exogenous NaA may be attributed to metabolites generated by the sequential action of cyclo-oxygenase and prostacyclin synthetase. On the other hand, the contractile action of exogenous NaA in diabetic atria may be ascribed to thromboxanes and lipoxygenase(s) metabolites.(ABSTRACT TRUNCATED AT 250 WORDS)
在正常大鼠和急性糖尿病(链脲佐菌素处理)大鼠的心房中,研究了对外源性花生四烯酸钠(NaA)的收缩反应。NaA在正常和糖尿病大鼠的心房中均诱导出浓度依赖性的正性肌力作用,但脂肪酸的收缩影响程度在两种类型的心房中有所不同,即糖尿病心房对NaA的反应性比正常制剂更高。通过环氧化酶(吲哚美辛和乙酰水杨酸)阻断花生四烯酸(AA)代谢,消除了NaA对正常和糖尿病心房的刺激作用。此外,用前列环素合成酶抑制剂反苯环丙胺孵育,可降低NaA对正常心房的正性肌力作用,但对糖尿病心房无影响。另一方面,血栓素(TX)合成酶抑制剂(咪唑和L-8027)可减弱NaA对糖尿病制剂的作用,而不改变对照组的收缩反应。在存在脂氧合酶阻断剂(去甲二氢愈创木酸和双硫腙)的情况下,仅在糖尿病大鼠的心房中,NaA的影响在正常水平时降低。两种心房制剂(正常和糖尿病)都将[1-14C]花生四烯酸(AA)转化为前列环素I2(以6-氧代-PGF1α评估)和血栓素B2。此外,正常心房产生的前列环素I2比血栓素B2多,而糖尿病心房中血栓素B2的产生大于前列环素I2。上述结果表明,在非糖尿病心房中,外源性NaA的作用可能归因于环氧化酶和前列环素合成酶顺序作用产生的代谢产物。另一方面,外源性NaA在糖尿病心房中的收缩作用可能归因于血栓素和脂氧合酶代谢产物。(摘要截断于250字)